Joyita Dutta
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study
Open Date: 2024-07-01
Close Date: 2029-04-30
Grant: Close
Super-Resolved Multimodal Imaging Biomarkers for Frontotemporal Dementia
Open Date: 2024-06-15
Close Date: 2026-03-31
Grant: Close
Early Alzheimers Forecasting from Multimodal Data via Deep Transfer Learning, Evaluated on a Large-Scale Prospective Cohort Study
Open Date: 2023-09-01
Close Date: 2025-08-31
Grant: Close
Longitudinal predictive modeling for tau in Alzheimer's disease
Open Date: 2021-09-01
Close Date: 2026-05-31
Grant: Close
Super-Resolution Tau PET Imaging for Alzheimer's Disease
Open Date: 2021-01-15
Close Date: 2024-12-31
Articles (20)
Year:
2026
Year:
2026
Alzheimer’s disease (AD) is the most common cause of dementia and a significant public health challenge. AD is characterized by the formation of tau and beta-amyloid (Aβ) protein aggregates in the brain, which can be imaged in vivo using positron emission tomography (PET). Integrating genetic and neuroimaging data using imaging genetics tools offers the potential to better understand disease mechanisms and risk factors in this heterogeneous disorder. Here, we present a framework based on Sparse Canonical Correlation Analysis (SCCA) integrated with clustering to identify AD subtypes from PET and genomic data. The SCCA clustering method was applied to tau PET scans (N = 541), Aβ PET scans (N = 907), and corresponding genomics data from the Alzheimer’s Disease Neuroimaging Initiative database. Test-retest studies were used to compare two different SCCA implementations, and longitudinal data were used to assess the stability of the subtyping approach. We identified four tau subtypes and two Aβ subtypes with distinct spatial deposition patterns, consistent with prior imaging studies. Genetic profiles associated with each subtype showed enrichment of specific biological pathways. Our findings suggest that SCCA clustering can help reveal biologically meaningful subtypes of AD. A clearer understanding of AD subtypes could ultimately improve AD diagnosis, prognosis, and treatment strategies.
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background While cortical atrophy has been widely studied in dementia, emerging evidence highlights the role of subcortical degeneration, particularly in deep gray matter structures such as the thalamus, claustrum, and basal nuclei, in both Alzheimer's disease (AD) and frontotemporal dementia (FTD). However, disease-specific subcortical patterns remain undercharacterized. Objective To quantify deep gray matter atrophy across the AD continuum (mild cognitive impairment and AD) and three FTD subtypes (bvFTD, svFTD, PNFA), and to assess longitudinal atrophy, cognitive associations, and diagnostic classification. Methods We applied a novel segmentation pipeline (sTHOMAS) to T1-weighted MRI data from 380 participants in the ADNI cohort and 274 participants in the FTLDNI cohort, with longitudinal follow-up available for 237 participants. Group differences were assessed using ANCOVA (adjusted for age and sex), followed by post hoc comparisons and effect size estimation (Cohen's d). Neuropsychological associations were examined using partial correlations. A hierarchical Random Forest model was trained to classify diagnostic groups. Results Pronounced atrophy was observed in the mediodorsal, anteroventral, pulvinar thalamic nuclei, and nucleus accumbens, and claustrum in both AD and FTD, but was significantly greater in bvFTD. Longitudinal analysis revealed the fastest progression in bvFTD. Classification achieved 96.8% accuracy (AUC = 0.99) for AD versus FTD and 77.7% accuracy (AUC = 0.83) for PNFA versus svFTD. Subcortical atrophy correlated to executive, language, and semantic deficits. Conclusions Atrophy in the mediodorsal, pulvinar, anteroventral thalamic nuclei, nucleus accumbens, and claustrum distinguishes AD from FTD and differentiates FTD subtypes. These subcortical structures represent promising biomarkers for diagnosis and monitoring of neurodegeneration.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (10)
Alberto Cacciola
Humanitas University
Michael Hornberger
Professor of Applied Dementia Research
University of Southampton
Nicolas Karakatsanis
Associate Professor of Biomedical Engineering
Weill Cornell Medical College
Guido Davidzon
Stanford University
Alejandro Bertolet
Assistant Professor
Massachusetts General Hospital
Steven R. Meikle
Head of Imaging Physics Lab
University of Sydney
Manoj Saranathan
Professor
-
Irene Buvat
CNRS Délégation Ile-de-France Sud
Kuangyu Shi
Head of Lab for Artificial Intelligence & Translational Theranostics
University of Bern
Quanzheng Li
Massachusetts General Hospital
Make your next move.
Prepare your application
Review drafts before you send them.